Mitsubishi UFJ Trust & Banking Corp Sells 46,458 Shares of Cardinal Health, Inc. $CAH

Mitsubishi UFJ Trust & Banking Corp lessened its stake in shares of Cardinal Health, Inc. (NYSE:CAH) by 13.3% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 301,709 shares of the company’s stock after selling 46,458 shares during the quarter. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.13% of Cardinal Health worth $50,687,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. National Pension Service grew its position in Cardinal Health by 0.6% during the 2nd quarter. National Pension Service now owns 466,667 shares of the company’s stock worth $78,400,000 after acquiring an additional 2,714 shares during the last quarter. Advyzon Investment Management LLC bought a new stake in shares of Cardinal Health during the second quarter worth about $210,000. Tiemann Investment Advisors LLC raised its holdings in Cardinal Health by 3.2% in the 2nd quarter. Tiemann Investment Advisors LLC now owns 3,230 shares of the company’s stock valued at $543,000 after buying an additional 100 shares during the last quarter. Fagan Associates Inc. acquired a new stake in Cardinal Health during the 2nd quarter worth approximately $213,000. Finally, Vise Technologies Inc. bought a new stake in Cardinal Health during the 2nd quarter worth approximately $1,011,000. 87.17% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

CAH has been the subject of several analyst reports. Argus raised their price target on shares of Cardinal Health from $189.00 to $211.00 and gave the company a “buy” rating in a research note on Tuesday, November 4th. Citigroup raised their target price on Cardinal Health from $165.00 to $190.00 and gave the stock a “neutral” rating in a research report on Friday, October 31st. Leerink Partners upped their price target on Cardinal Health from $187.00 to $211.00 in a research report on Friday, October 31st. UBS Group increased their price target on Cardinal Health from $185.00 to $220.00 and gave the company a “buy” rating in a research note on Friday, October 31st. Finally, Evercore ISI lifted their price objective on Cardinal Health from $190.00 to $220.00 and gave the stock an “outperform” rating in a research note on Friday, October 31st. Twelve analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $205.00.

Cardinal Health Price Performance

CAH stock opened at $204.14 on Thursday. The company’s 50-day moving average is $163.33 and its 200-day moving average is $158.16. The stock has a market capitalization of $48.50 billion, a PE ratio of 31.65, a price-to-earnings-growth ratio of 1.39 and a beta of 0.72. Cardinal Health, Inc. has a 1 year low of $114.60 and a 1 year high of $207.47.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Thursday, October 30th. The company reported $2.55 earnings per share for the quarter, topping analysts’ consensus estimates of $2.22 by $0.33. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The business had revenue of $64.01 billion for the quarter, compared to the consensus estimate of $59.41 billion. During the same period in the prior year, the business earned $1.88 EPS. The firm’s revenue for the quarter was up 22.4% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. On average, analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, January 2nd. Cardinal Health’s payout ratio is 30.77%.

Insider Activity

In other news, CEO Stephen M. Mason sold 41,575 shares of Cardinal Health stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $6,187,191.50. Following the completion of the transaction, the chief executive officer directly owned 26,085 shares in the company, valued at $3,881,969.70. This trade represents a 61.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Ola M. Snow sold 28,151 shares of the company’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.94, for a total transaction of $4,192,809.94. Following the completion of the sale, the insider owned 15,431 shares in the company, valued at $2,298,293.14. This represents a 64.59% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is currently owned by insiders.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.